Course description
A large amount of intellectual property rights (IPR) litigation surrounds infringement claims made by one party followed by the defendant challenging the validity of their IPR. Whilst these disputes are usually resolved by settlement agreements, these arrangements themselves can raise their own competition concerns, which practitioners working in this area need to thoroughly understand in order to best serve their clients.
Suzanne Rab presents this comprehensive and informative webinar which surveys the recent cases and litigation and their renewed focus on competition concerns, especially in the pharmaceutical sector. For an exploration of how settlements concluded in the context of IPR licensing can raise competition law compliance issues, book now.
Upcoming start dates
Outcome / Qualification etc.
Training Course Content
Introduction
A common area for intellectual property rights (‘IPR’) litigation concerns the situation where one party alleges infringement of its IPR, and the defendant challenges the validity of that IPR.
Many such disputes have been resolved by settlement agreements, but such arrangements can themselves raise their own competition concerns.
Competition law cases in the pharmaceutical sector since the European Commission’s final report have tended to focus on settlement agreements between originators and originators.
This has also been an area of antitrust scrutiny in the USA.
Recent cases and litigation suggest a renewed focus on competition concerns in settlement agreements with implications in and beyond the pharmaceutical sector.
This new webinar provides an exploration of how settlements concluded in the context of IPR licensing can raise competition law compliance issues.
What You Will Learn
This webinar will cover the following:
- A reminder of how UK and EU competition law affects settlement licensing agreements
- Spotlight on patent licensing and ‘pay for delay’ cases in the UK, EU, and USA
- Update on recent high-profile UK and EU cases including Laboratories Servier and GSK
- Practical case study
- Top tips for risk management
Expenses
MBL Seminars Limited
MBL is a leading learning and development provider for professional service firms. Over the past 18 years, more than 198,000 people across 23,000 different organisations spanning 81 countries, have chosen us to deliver their training. With over 800 expert speakers...